Natus Medical Inc (BABY) Sees Significant Decline in Short Interest

Natus Medical Inc (NASDAQ:BABY) saw a significant drop in short interest during the month of January. As of January 12th, there was short interest totalling 1,963,041 shares, a drop of 33.3% from the December 29th total of 2,945,067 shares. Approximately 6.6% of the shares of the company are short sold. Based on an average daily trading volume, of 1,200,756 shares, the days-to-cover ratio is presently 1.6 days.

Shares of Natus Medical (NASDAQ:BABY) opened at $30.85 on Friday. Natus Medical has a one year low of $28.05 and a one year high of $43.60. The company has a current ratio of 4.21, a quick ratio of 3.36 and a debt-to-equity ratio of 0.36. The firm has a market cap of $979.80, a PE ratio of -342.74 and a beta of 0.84.

BABY has been the topic of a number of recent research reports. Zacks Investment Research upgraded Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a research note on Tuesday, October 24th. BidaskClub cut Natus Medical from a “hold” rating to a “sell” rating in a research note on Saturday, December 9th. William Blair cut shares of Natus Medical from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. Finally, Benchmark restated a “buy” rating and set a $49.00 price objective (down from $55.00) on shares of Natus Medical in a research note on Tuesday, January 16th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $47.00.

In other Natus Medical news, Director William M. Moore sold 5,000 shares of the firm’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $41.01, for a total value of $205,050.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Dong Chune Christopher Chung sold 12,642 shares of the firm’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $42.91, for a total value of $542,468.22. Following the completion of the sale, the vice president now owns 141,414 shares in the company, valued at $6,068,074.74. The disclosure for this sale can be found here. Company insiders own 5.50% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of BABY. Alliancebernstein L.P. raised its stake in shares of Natus Medical by 2.3% during the second quarter. Alliancebernstein L.P. now owns 53,756 shares of the medical equipment provider’s stock valued at $2,005,000 after purchasing an additional 1,190 shares in the last quarter. Riverhead Capital Management LLC raised its position in Natus Medical by 90.9% in the second quarter. Riverhead Capital Management LLC now owns 2,864 shares of the medical equipment provider’s stock worth $107,000 after acquiring an additional 1,364 shares in the last quarter. Teachers Advisors LLC raised its position in Natus Medical by 1.0% in the second quarter. Teachers Advisors LLC now owns 311,516 shares of the medical equipment provider’s stock worth $11,620,000 after acquiring an additional 3,123 shares in the last quarter. BlackRock Inc. raised its position in Natus Medical by 0.6% in the second quarter. BlackRock Inc. now owns 4,149,535 shares of the medical equipment provider’s stock worth $154,779,000 after acquiring an additional 25,340 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its position in Natus Medical by 2.0% in the second quarter. PNC Financial Services Group Inc. now owns 71,871 shares of the medical equipment provider’s stock worth $2,681,000 after acquiring an additional 1,430 shares in the last quarter. Institutional investors and hedge funds own 99.74% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Natus Medical Inc (BABY) Sees Significant Decline in Short Interest” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.com-unik.info/2018/02/02/natus-medical-inc-baby-sees-significant-decline-in-short-interest.html.

About Natus Medical

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit